Echimes

Echimes is a specialized Contract Research Organization (CRO) providing comprehensive Drug Metabolism and Pharmacokinetics (DMPK) and bioanalysis services to the global pharmaceutical and biotechnology industries. Headquartered in Suzhou, China, the company offers a wide range of services including in vitro ADME, in vivo PK, and metabolite identification (MetID) to support drug discovery and development. Echimes is particularly recognized for its expertise in 'new modalities,' offering specialized DMPK solutions for PROTACs, oligonucleotides, peptides, and antibody-drug conjugates (ADCs). By leveraging advanced LC-MS/MS and high-resolution mass spectrometry technologies, the company delivers high-quality, regulatory-compliant data to help clients optimize lead compounds and accelerate their pipelines.